Fairfield Market Research Cancer Registry Software Market Size, Statistics, Trends 2030

Cancer Registry Software Market

Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Published Date: Upcoming | Format:

Industry: Healthcare IT

Request TOC Request Customization $4,995.00Prebook

This study intends to analyse diverse aspects of the global cancer registry software market. The insights offered in this report are expected to aid in market growth examination over the forecast timeline.

Market Analysis in Brief

The global cancer registry software market refers to the market for software solutions designed to help healthcare organizations track and manage data related to cancer cases. Cancer registry software typically includes tools for collecting, managing, analysing, and reporting cancer-related data, such as patient demographics, diagnosis, and treatment information, as well as outcomes. The market for cancer registry software is driven by the growing prevalence of cancer worldwide, as well as the increasing adoption of electronic health records (EHRs), and other digital health technologies. Cancer registry software is used by a wide range of healthcare organizations, including hospitals, clinics, research institutions, and government agencies. This market is expected to continue to grow in the coming years as healthcare organizations look to increasingly use data analytics and other advanced technologies to improve cancer prevention, diagnosis, and treatment.

Key Report Findings

  • The global cancer registry software market was valued at over US$56 Mn in 2020
  • The cloud-based deployment mode segment is expected to registry the highest growth rate
  • Adoption will be the highest across hospitals and clinics accounts for the largest share of the market
  • The Asia Pacific region is projected to index the highest growth rate over the forecast period

Growth Drivers

Greater Awareness, and the Increasing Incidence of Cancers

In recent years, there has been a steady increase in the number of individuals who are more aware of early detection and cancer screening processes owing to the highly beneficial data they offer to both patients and physicians. This has led to a spike in the number of individuals being treated for cancer, thus boosting the demand for cancer registry software solutions in the process.

Another element resulting in higher awareness is the increasing incidence of cancer worldwide. Cancer registry software helps to maintain and manage cancer patient data, making it crucial for further cancer research and treatment. Additionally, the increasing need for data analytics in the healthcare sector is also expected to profoundly influence the growth trajectory of the global cancer registry software market in the years ahead.

Technological Advancements, and Favorable Governmental Initiatives

The implementation of ongoing technological developments and advancements such as machine learning, cloud computing, and Artificial Intelligence has allowed cancer registry software to provide more comprehensive and accurate cancer data. This has led to a higher adoption of cancer registry software by healthcare providers. Moreover, an increasing number of governments are rolling out initiatives to improve cancer care and management, which are expected to boost the demand for cancer registry software solutions. For example, the National Program of Cancer Registries (NPCR) was established by the US government to collect and disseminate cancer information. Factors such as these are also expected to augment growth of the global cancer registry software market.  

Growth Challenges

Data Quality Challenges, High Costs, and Lack of Skilled Professionals

Data entry errors, missing data, and inconsistencies in coding can limit the usefulness of cancer registry data for research and treatment applications, as this affects its accuracy and completeness. Additionally, cancer registry software can be expensive, which limit its adoption, particularly for smaller healthcare organizations. Moreover, this software requires skilled professionals to manage and analyse its data. A lack of these professionals to effectively use this software could also restrict its adoption. Factors such as these are expected to a growth deterrent for players engaged in the global cancer registry software market.

Growth Opportunities Across Regions

North America to Remain a Regional Frontrunner

Europe is expected to account for a sizeable part of the global cancer registry software market owing to factors such as the increasing adoption of EHRs as well as a high demand for cancer data analysis. The Asia Pacific region is also expected to expand at a favorable rate over the forecast period due to the growing adoption of healthcare IT solutions and the increasing incidence of cancer.

However, North America is expected to remain the regional frontrunner in the coming years owing to the significant presence of industry players, a well-established healthcare infrastructure, and favorable initiatives that are effectively promoted by respective governments in this region.

Key Market Players – Cancer Registry Software Landscape

Some key companies in the global cancer registry software market include Elekta AB, Onco Inc., C/NET Solutions, McKesson Corporation, IBM Watson Health, Himagine Solutions Inc., Electronic Registry Systems (ERS), Conduent Inc., Onsemble, and Ordinal Data Inc., to name a few. Key players in the cancer registry software industry have been involved in new product launches and are implementing other growth strategies such as collaborations and acquisitions to strengthen their position.

Cancer Registry Software Market: Key Developments

  • In 2021, Elekta AB acquired Kaiku Health, a platform for digital health interventions. This was done to boost Kaiku Health’s digital cancer patient monitoring and reporting capabilities
  • In 2021, Onco Inc. Launched its OncoLogue platform, which uses AI (Artificial Intelligence) and machine learning algorithms to provide personalized cancer care management
  • In 2021, C/NET Solutions launched web-based cancer registry software solution. This software provides real-time cancer management and analysis for healthcare providers
  • In 2020m the American College of Surgeons launched its National Cancer Database (NCDB) Participant User File (PUF), which provides cancer registry data for research and analysis applications
  • In 2020, CancerIQ launched its Precision Health Platform, which provides genetic testing and counselling services for cancer risk assessment and management

Regional Classification of the Global Cancer Registry Software Market is Listed Below:

North America

  • U.S.
  • Canada


  • Germany
  • France
  • Spain
  • U.K.
  • Italy
  • Russia
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

 Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East and Africa

  • GCC
  • South Africa
  • Rest of Middle East & Africa

*Regions and countries are subject to change based on data availability.

Key Elements Included In The Study: Global Cancer Registry Software Market

  • Cancer Registry Software Market by Product/Technology/Grade, Application/End-user, and Region
  • Executive Summary (Opportunity Analysis and Key Trends)
  • Historical Market Size and Estimates, Value, 2018 - 2022
  • Market Value at Regional and Country Level, 2023 - 2030
  • Market Dynamics and Economic Overview
  • Market Size in Value, Growth Rates, and Forecast Figures, 2023 - 2030
  • Competitive Intelligence with Financials, Key Developments, and Portfolio of Leading Companies 
  • Regional and Product/Grade/Application/End-user Price Trends Analysis
  • Value Chain and Five Force’s Analysis
  • Regional/Sub-region/Country Market Size and Trend Analysis
  • Company Market Share Analysis and Key Player Profiles

Post Sale Support, Research Updates & Offerings

We value the trust shown by our customers in Fairfield Market Research. We support our clients through our post sale support, research updates and offerings.

  • The report will be prepared in a PPT format and will be delivered in a PDF format.
  • Additionally, Market Estimation and Forecast numbers will be shared in Excel Workbook.
  • If a report being sold was published over a year ago, we will offer a complimentary copy of the updated research report along with Market Estimation and Forecast numbers within 2-3 weeks’ time of the sale.
  • If we update this research study within the next 2 quarters, post purchase of the report, we will offer a Complimentary copy of the updated Market Estimation and Forecast numbers in Excel Workbook.
  • If there is a geopolitical conflict, pandemic, recession, and the like which can impact global economic scenario and business activity, which might entirely alter the market dynamics or future projections in the industry, we will create a Research Update upon your request at a nominal charge.

Request Table of Contents

Our Research Methodology

Considering the volatility of business today, traditional approaches to strategizing a game plan can be unfruitful if not detrimental. True ambiguity is no way to determine a forecast. A myriad of predetermined factors must be accounted for such as the degree of risk involved, the magnitude of circumstances, as well as conditions or consequences that are not known or unpredictable. To circumvent binary views that cast uncertainty, the application of market research intelligence to strategically posture, move, and enable actionable outcomes is necessary.

View Methodology
Fairfield Quality assured
Fairfield Confidentiality assured
Fairfield Custom research services